Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 37 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
17 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY from Gent, company number BE0456343923, closed financial year 2025 with a result of € 10.6 million after tax. For that financial year VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY recorded revenue of € 52.6 million and equity of € 172.4 million. Compared with financial year 2024, the result moved from € 2.7 million to € 10.6 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 22, 2026.
€ 172.4 million
▲ 7% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 10.6 million
▲ 295% vs 2024
Profit after tax over the fiscal year.
€ 5 million
▼ 30% vs 2024
Cash and bank balances on the last day of the fiscal year.
People and assets in 2025
928.4
▲ 43.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 100.5 million
▲ 8% vs 2024
€ 108,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 606,902
▼ 16% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 13.4 million
▲ 46% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 77 days on average.
€ 18.4 million
▲ 9% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 36,927,925 | € 42,443,212 | € 44,049,791 | € 52,617,208 | ▲ 19% |
| Profit after taxes | € -5,246,152 | € 6,096,869 | € 2,676,451 | € 10,562,460 | ▲ 295% |
| Equity | € 154,186,843 | € 159,549,548 | € 161,113,789 | € 172,385,123 | ▲ 7% |
| Total debts | € 116,461,065 | € 135,871,441 | € 147,947,111 | € 151,336,926 | ▲ 2% |
| Cash | € 29,878,247 | € 18,361,793 | € 7,167,100 | € 4,996,040 | ▼ 30% |
| Land & buildings | € 7,110,451 | € 5,994,384 | € 5,660,519 | € 5,288,766 | ▼ 7% |
| Retained profit | € 115,716,675 | € 121,813,544 | € 124,489,995 | € 135,052,455 | ▲ 8% |
| Bank debt | € 1,249,994 | € 449,726 | € 229,183 | € 0 | ▼ 100% |
| Balance sheet total | € 270,647,908 | € 295,420,989 | € 309,060,900 | € 323,722,049 | ▲ 5% |
| Employees (FTE) | 796 | 835.2 | 885.2 | 928.4 | ▲ 43.2 |
Key figures of VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY?
What happened at VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- CHRIS DE JONGHE stepped down as director. NBB
- BART DE MOOR stepped down as director. NBB
- LUC MOENS stepped down as director. NBB
- MAARTEN WEYN stepped down as director. NBB
- DIETER DEFORCE stepped down as director. NBB
- PETER SCHELKENS stepped down as director. NBB
- GRIET NUYTINCK stepped down as director. NBB
- AJIT SHETTY stepped down as director. NBB
In short
From € 5.2 million loss in 2022 to € 10.6 million profit in 2025.
Best year ever: 2025, with € 10.6 million profit.
Pays suppliers within 77 days on average.
Management
It owns 100% of BIOTOPE GENERAL PARTNER, 75% of RAINBOW CROPS, 60% of VIB BIO-INCUBATOR, 52.3% of TRIM THERAPEUTICS, 50% of BIO INCUBATOR BRUSSELS and 35.1% of BIO-INCUBATOR LEUVEN itself.
Directors
According to the 2025 annual accounts
KATHARINA D'HERDE
Director
since 2023 · until 2026
since 2017 · until 2025
since 2025 · until 2029
since 2025 · until 2026
since 1995 · until 2025
AJIT SHETTY
Chairman of the board
since 2012 · until 2027
STEFAAN VAES
Director
since 2025 · until 2026
BART DE MOOR
Director
Also active at: Alamire Foundation, TRANSPORT & MOBILITY LEUVEN, UNIVERSITAIR CENTRUM SINT-IGNATIUS ANTWERPEN, OFFICENTER IMMO LEUVEN, Health House, Capricorn Digital Growth Fund, Vlaams Datanutsbedrijf, Frascati Symphonic
since 1995 · until 2029
since 2019 · until 2025
LUC MOENS
Vice-chairman of the board
since 2007 · until 2029
since 2025 · until 2029
since 2016 · until 2029
KOEN QUAGHEBEUR
Director
Also active at: HEDERA 22, MINAGRO, Q-Terra, Glob-Agro, LIKALO, Q-CHEM, K & E, GEESTRIJK
since 2020 · until 2026
since 2024 · until 2029
GERARD GOOVERS
Director
since 2017 · until 2025
MARLEEN LIMBOURG
Director
since 2018 · until 2027
GRIET NUYTINCK
Director
Also active at: Antwerp Symphony Orchestra, Collegium Vocale Gent, Orpheus Instituut
since 2019 · until 2029
Establishments
Establishment units
Physical locations of this company
Suzanne Tassierstraat 1
9052 Gent
Technologiepark-Zwijnaarde 71
9052 Gent
Active since 6 July 1995
Herestraat 49
3000 Leuven
Active since 6 July 1995
Pleinlaan 2
1050 Elsene
Active since 6 July 1995
Universiteitsplein 1
2610 Antwerpen
Active since 6 July 1995
Technologiepark-Zwijnaarde 75
9052 Gent
Active since 6 July 1995
Kasteelpark Arenberg 31
3001 Leuven
Active since 6 July 1995
Gaston Geenslaan 1
3001 Leuven
Active since 1 January 2009
Herestraat 49 box box 4039
3000 Leuven
Active since 1 December 2010
Minderbroedersstraat 10 box X
3000 Leuven
Active since 1 January 2014
Corneel Heymanslaan 10
9000 Gent
Active since 1 January 2015
Agoralaan gebouw c
3590 Diepenbeek
Active since 1 March 2016
Technologiepark-Zwijnaarde 122
9052 Gent
Active since 1 January 2018
Celestijnenlaan 200 box R
3001 Leuven
Active since 1 October 2017
Technologiepark-Zwijnaarde 104B
9052 Gent
Active since 1 January 2019
Kerrebroek 66B
9850 Deinze
Active since 16 December 2020
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 17 companies are registered at this address.
All companies at this address →ORIONIS BIOSCIENCES
€ 11.6 million revenue · 2025
LO²CUS Gent
€ 1.7 million gross margin · 2024
S-Biomedic
€ 4.4 million gross margin · 2025
VIB BIO-INCUBATOR same network
€ 536,162 gross margin · 2025
272BIO
€ 104,252 gross margin · 2025
+12 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0456.343.923
- VAT number
- BE 0456.343.923
- Registered office
- Suzanne Tassierstraat 1, 9052 Gent
- Names & denominations
- VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY · VIB
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 6 July 1995
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Speur- en ontwikkelingswerk op natuurwetenschappelijk gebied